SCHEMBL4153734

SCHEMBL4153734

CC(C)(C)c1cc(CCC(=O)OCCC(COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)(COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.51
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.43
ALOX5 P09917 1/20 0.42
APP P05067 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 2/20 0.39
PKM P14618 1/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPK1 P28482 2/20 0.39
BLM P54132 2/20 0.39
ATM Q13315 2/20 0.39
HIF1A Q16665 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657927 0.97 GAA (0.51) GAAKMT2AMEN1ALOX5APP
SCHEMBL4764337 0.94 GAA (0.54) GAAKMT2AMEN1ALOX5APP
SCHEMBL30209 0.90 GAA (0.57) GAAKMT2AMEN1ALOX5HTT
SCHEMBL208761 0.90 GAA (0.60) GAAKMT2AMEN1ALOX5APP
SCHEMBL22451057 0.89 GAA (0.54) GAAKMT2AMEN1ALOX5APP
SCHEMBL29923229 0.89 GAA (0.56) GAAKMT2AMEN1ALOX5HTT
SCHEMBL29764272 0.89 GAA (0.56) GAAKMT2AMEN1ALOX5HTT
SCHEMBL9467415 0.88 GAA (0.50) GAAKMT2AMEN1ALOX5APP
SCHEMBL19663372 0.88 GAA (0.50) GAAKMT2AMEN1ALOX5APP
SCHEMBL13408633 0.88 GAA (0.50) GAAKMT2AMEN1ALOX5HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054698-A1 Granular Polymer Additives and Their Preparation ALBEMARLE CORPORATION (US) 2009-02-26 US disclosed
US-7425290-B2 Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying ALBEMARLE CORPORATION (US) 2008-09-16 US disclosed
EP-1700318-A1 PROCESS FOR MANUFACTURING A SELF-EXTINGUISHING CABLE Prysmian Cavi e Sistemi Energia S.r.l. (IT) 2006-09-13 EP disclosed
WO-2005062315-A1 PROCESS FOR MANUFACTURING A SELF-EXTINGUISHING CABLE PRYSMIAN CAVI E SISTEMI ENERGIA S.R.L. (IT) 2005-07-07 WO disclosed
US-20050009725-A1 Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying ALBEMARLE CORPORATION 2005-01-13 US disclosed
EP-1363972-A1 GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION ALBEMARLE CORPORATION (US) 2003-11-26 EP disclosed
WO-2002068523-A1 GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION ALBEMARLE CORPORATION (US) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054698-A1 Granular Polymer Additives and Their Preparation GRN, C9, COG4 GAA 62/4885KMT2A 4633/4885MEN1 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.